Autolus enters $250M senior secured notes facility with Perceptive; initial $75M drawn

Autolus Therapeutics plc

Issued $75M Tranche 1 Notes under $250M facility; additional $175M available in three tranches subject to revenue milestones.
Notes mature July 30, 2031; interest rate = 1-month SOFR + 3.50% floor + margin 6.75%-7.25% based on revenue.
Issued warrant to Perceptive for 3.5M ADSs at $1.9314 (25% premium to 30-day VWAP); additional warrants for future tranches.
Proceeds for general corporate purposes; facility secured by substantially all assets of company and guarantors.
Financial covenants: minimum liquidity $12.5M-$50M and minimum consolidated net revenue thresholds.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.